Feasibility of Integrating Olfactory Stimuli Into Virtual Reality Cue Exposure for Patients With Alcohol Dependence
Key facts
- Who runs it
- Charite University, Berlin, Germany
- Where
- Germany1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 20 people enrolled
- Started
- 7 Mar 2026
- Ended
- 9 Sept 2026
- Type of study
- Interventional
- Treatments tested
- VR Cue-Exposure Including Olfactory Stimuli
- Record updated
- 20 October 2026
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (13)Hide the full registry criteria
Who can take part
- age: 18-65 years
- diagnosis of alcohol dependence according to ICD-10 (F10.2)
- history of alcohol craving
- able to provide written informed consent
Who cannot take part
- concurrent pharmacological treatment targeting AUD (e.g. benzodiazepines) or craving (e.g. acamprosate, disulfiram, naltrexone, nalmefene) and further medication significantly influencing heart rate
- severe neuropsychiatric disorder (e.g. schizophrenia spectrum disorders, bipolar affective disorder) or substantial cognitive impairment
- serious illnesses affecting brain or heart function that influence physiological study parameters
- hyposmia
- dependence on substances other than alcohol and nicotine
- current alcohol intoxication (randomly tested by measurement of breath alcohol concentration)
- unable to understand the study information, consent form or principles of the study
- abstinence for less than 7 days or ongoing consumption of alcohol
- acute suicidality (or acute endangerment of others)
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Alcohol dependence (AD) is a prevalent and burdensome clinical condition with high relapse rates. A central risk factor for relapse is craving for alcohol, which can be evoked by both real-world and virtual cues in immersive Virtual Reality (VR). In addition to visual and auditory stimuli, olfactory stimuli are increasingly recognized as important for creating realistic, multisensory VR environments. However, no systematic investigation has yet examined how olfactory stimuli embedded in VR-based Cue Exposure (VR-CE) influence cue-elicited craving. As part of the OLFA-VR (Effects of Olfactory Stimuli in Virtual Reality Cue Exposure on Craving in Alcohol Dependence) research project, the present feasibility study aims to evaluate the feasibility, tolerability and acceptability of implementing olfactory stimuli into VR-CE.
Read full original descriptionShow less
In addition, this study not only examines the general feasibility of alcohol-related olfactory stimuli in VR-CE but also explores which specific alcohol-related olfactory stimuli prove to be feasible.
The investigators hypothesize that implementing olfactory stimuli into VR-CE will be feasible and tolerable for patients with AD, with no preventable serious side effects caused by VR-CE. The investigators also hypothesize that VR-CE will induce craving in most patients.
The group in the trial
- Olfactory VRTreatment being tested
neutral and alcohol-related olfactory and visual stimuli in a Virtual Reality Cue Exposure
Treatment: VR Cue-Exposure Including Olfactory Stimuli
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 20 October 2026